PARLIAMENTARY WRITTEN QUESTION
Transplant Surgery: Coronavirus (10 December 2020)

Solid organ transplant recipients were identified at the start of the pandemic as one of the groups of patients at highest clinical risk of COVID-19 and therefore were included in the agreed list of clinically extremely vulnerable patients. Throughout the pandemic, healthcare providers were asked to ensure care for these patients is personalised and takes account of individual circumstances such as COVID-19 risk and the impact of shielding on health and wellbeing. Such patients were able to access government support, including delivery of food and medicines and clinical advice through various routes.